ARGENX SE (1AE.DE) Fundamental Analysis & Valuation

FRA:1AE • NL0010832176

Current stock price

667.6 EUR
+11.8 (+1.8%)
Last:

This 1AE.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. 1AE.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 1AE was profitable.
  • In the past year 1AE had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: 1AE reported negative net income in multiple years.
  • In the past 5 years 1AE reported 4 times negative operating cash flow.
1AE.DE Yearly Net Income VS EBIT VS OCF VS FCF1AE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

  • The Return On Assets of 1AE (23.62%) is better than 97.22% of its industry peers.
  • 1AE has a better Return On Equity (28.01%) than 94.44% of its industry peers.
  • 1AE has a better Return On Invested Capital (16.84%) than 94.44% of its industry peers.
Industry RankSector Rank
ROA 23.62%
ROE 28.01%
ROIC 16.84%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1AE.DE Yearly ROA, ROE, ROIC1AE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • 1AE's Profit Margin of 29.23% is amongst the best of the industry. 1AE outperforms 90.28% of its industry peers.
  • 1AE has a better Operating Margin (25.10%) than 80.56% of its industry peers.
  • 1AE's Gross Margin of 89.29% is amongst the best of the industry. 1AE outperforms 86.11% of its industry peers.
  • 1AE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.1%
PM (TTM) 29.23%
GM 89.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.34%
GM growth 5YN/A
1AE.DE Yearly Profit, Operating, Gross Margins1AE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

9

2. 1AE.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1AE is creating value.
  • 1AE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1AE.DE Yearly Shares Outstanding1AE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
1AE.DE Yearly Total Debt VS Total Assets1AE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • 1AE has an Altman-Z score of 23.85. This indicates that 1AE is financially healthy and has little risk of bankruptcy at the moment.
  • 1AE has a better Altman-Z score (23.85) than 93.06% of its industry peers.
  • 1AE has a debt to FCF ratio of 0.08. This is a very positive value and a sign of high solvency as it would only need 0.08 years to pay back of all of its debts.
  • The Debt to FCF ratio of 1AE (0.08) is better than 95.83% of its industry peers.
  • 1AE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.00, 1AE belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.08
Altman-Z 23.85
ROIC/WACC2.27
WACC7.43%
1AE.DE Yearly LT Debt VS Equity VS FCF1AE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

2.3 Liquidity

  • A Current Ratio of 5.23 indicates that 1AE has no problem at all paying its short term obligations.
  • The Current ratio of 1AE (5.23) is better than 80.56% of its industry peers.
  • A Quick Ratio of 4.87 indicates that 1AE has no problem at all paying its short term obligations.
  • 1AE has a Quick ratio of 4.87. This is amongst the best in the industry. 1AE outperforms 80.56% of its industry peers.
Industry RankSector Rank
Current Ratio 5.23
Quick Ratio 4.87
1AE.DE Yearly Current Assets VS Current Liabilites1AE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. 1AE.DE Growth Analysis

3.1 Past

  • 1AE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1028.32%, which is quite impressive.
  • Looking at the last year, 1AE shows a very strong growth in Revenue. The Revenue has grown by 220.39%.
  • The Revenue has been growing by 151.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1028.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%762.37%
Revenue 1Y (TTM)220.39%
Revenue growth 3Y116.21%
Revenue growth 5Y151.52%
Sales Q2Q%79.03%

3.2 Future

  • Based on estimates for the next years, 1AE will show a very strong growth in Earnings Per Share. The EPS will grow by 28.43% on average per year.
  • The Revenue is expected to grow by 21.30% on average over the next years. This is a very strong growth
EPS Next Y39.01%
EPS Next 2Y33.72%
EPS Next 3Y33.15%
EPS Next 5Y28.43%
Revenue Next Year42.02%
Revenue Next 2Y31.01%
Revenue Next 3Y26.81%
Revenue Next 5Y21.3%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1AE.DE Yearly Revenue VS Estimates1AE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
1AE.DE Yearly EPS VS Estimates1AE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 20 40 60 80

5

4. 1AE.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 40.02, 1AE can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, 1AE is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • 1AE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.51.
  • The Price/Forward Earnings ratio is 28.79, which means the current valuation is very expensive for 1AE.
  • Based on the Price/Forward Earnings ratio, 1AE is valued cheaper than 80.56% of the companies in the same industry.
  • 1AE's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 21.41.
Industry RankSector Rank
PE 40.02
Fwd PE 28.79
1AE.DE Price Earnings VS Forward Price Earnings1AE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1AE is valued a bit cheaper than the industry average as 70.83% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, 1AE is valued a bit cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 84.71
EV/EBITDA 24.17
1AE.DE Per share data1AE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • 1AE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of 1AE may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1AE's earnings are expected to grow with 33.15% in the coming years.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y33.72%
EPS Next 3Y33.15%

0

5. 1AE.DE Dividend Analysis

5.1 Amount

  • No dividends for 1AE!.
Industry RankSector Rank
Dividend Yield 0%

1AE.DE Fundamentals: All Metrics, Ratios and Statistics

ARGENX SE

FRA:1AE (4/30/2026, 7:00:00 PM)

667.6

+11.8 (+1.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength32.43
Industry Growth77.33
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners45.26%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap41.52B
Revenue(TTM)7.02B
Net Income(TTM)2.05B
Analysts84.8
Price Target894.08 (33.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.49%
Min EPS beat(2)18.63%
Max EPS beat(2)28.35%
EPS beat(4)4
Avg EPS beat(4)19.32%
Min EPS beat(4)7.11%
Max EPS beat(4)28.35%
EPS beat(8)6
Avg EPS beat(8)2001.87%
EPS beat(12)9
Avg EPS beat(12)1341.86%
EPS beat(16)12
Avg EPS beat(16)1013.44%
Revenue beat(2)2
Avg Revenue beat(2)3.6%
Min Revenue beat(2)0.3%
Max Revenue beat(2)6.9%
Revenue beat(4)3
Avg Revenue beat(4)3.64%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)8.17%
Revenue beat(8)6
Avg Revenue beat(8)3.1%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.66%
PT rev (3m)2.94%
EPS NQ rev (1m)-2.88%
EPS NQ rev (3m)-17.58%
EPS NY rev (1m)-2.74%
EPS NY rev (3m)-9.49%
Revenue NQ rev (1m)0.45%
Revenue NQ rev (3m)1.28%
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)3.82%
Valuation
Industry RankSector Rank
PE 40.02
Fwd PE 28.79
P/S 6.92
P/FCF 84.71
P/OCF 70.91
P/B 6.63
P/tB 6.89
EV/EBITDA 24.17
EPS(TTM)16.68
EY2.5%
EPS(NY)23.19
Fwd EY3.47%
FCF(TTM)7.88
FCFY1.18%
OCF(TTM)9.42
OCFY1.41%
SpS96.43
BVpS100.63
TBVpS96.89
PEG (NY)1.03
PEG (5Y)N/A
Graham Number194.333 (-70.89%)
Profitability
Industry RankSector Rank
ROA 23.62%
ROE 28.01%
ROCE 23.92%
ROIC 16.84%
ROICexc 42.43%
ROICexgc 46.78%
OM 25.1%
PM (TTM) 29.23%
GM 89.29%
FCFM 8.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.34%
GM growth 5YN/A
F-Score5
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.08
Debt/EBITDA 0.02
Cap/Depr 397.41%
Cap/Sales 1.59%
Interest Coverage 1956.95
Cash Conversion 38.29%
Profit Quality 27.96%
Current Ratio 5.23
Quick Ratio 4.87
Altman-Z 23.85
F-Score5
WACC7.43%
ROIC/WACC2.27
Cap/Depr(3y)275.49%
Cap/Depr(5y)599.15%
Cap/Sales(3y)3.13%
Cap/Sales(5y)11.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1028.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%762.37%
EPS Next Y39.01%
EPS Next 2Y33.72%
EPS Next 3Y33.15%
EPS Next 5Y28.43%
Revenue 1Y (TTM)220.39%
Revenue growth 3Y116.21%
Revenue growth 5Y151.52%
Sales Q2Q%79.03%
Revenue Next Year42.02%
Revenue Next 2Y31.01%
Revenue Next 3Y26.81%
Revenue Next 5Y21.3%
EBIT growth 1Y12671.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.83%
EBIT Next 3Y45.45%
EBIT Next 5Y31.89%
FCF growth 1Y479.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y928.06%
OCF growth 3YN/A
OCF growth 5YN/A

ARGENX SE / 1AE.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ARGENX SE (1AE.DE) stock?

ChartMill assigns a fundamental rating of 7 / 10 to 1AE.DE.


What is the valuation status of ARGENX SE (1AE.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to ARGENX SE (1AE.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ARGENX SE?

ARGENX SE (1AE.DE) has a profitability rating of 6 / 10.


What is the valuation of ARGENX SE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARGENX SE (1AE.DE) is 40.02 and the Price/Book (PB) ratio is 6.63.


What is the expected EPS growth for ARGENX SE (1AE.DE) stock?

The Earnings per Share (EPS) of ARGENX SE (1AE.DE) is expected to grow by 39.01% in the next year.